Vi has introduced a new suite of AI agents tailored for healthcare, life sciences, and wellness sectors, while simultaneously completing a $145 million funding round that values the company at $1.64 billion.
The recently launched AI agents serve as an execution layer across Vi's applications—Activate, Engage, and Operate—aiming to enhance decision-making for patients, care teams, and operational workflows. Leveraging one of the largest datasets of clinical and operational signals, these agents facilitate real-time decision-making, driving improvements in areas such as patient care navigation, clinical trial acceleration, and drug commercialization.
Vi's existing impact is significant, with over 100 enterprise customers and contributions to the market launch of more than 50 drugs, collectively supporting over 190 million lives and generating more than $2 billion in value for partners. The company envisions a future where healthcare accessibility is universal and affordable, regardless of socioeconomic status.
In addition to the product launch, the $145 million funding round, which includes both secondary and primary capital, is intended to bolster talent acquisition, enhance the platform, and strengthen the financial standing of the company. This strategic move positions Vi for continued growth in the rapidly evolving healthcare AI landscape.